Ignite Creation Date:
2025-12-24 @ 11:25 PM
Ignite Modification Date:
2026-01-01 @ 12:09 PM
Study NCT ID:
NCT00782756
Status:
COMPLETED
Last Update Posted:
2018-02-06
First Post:
2008-10-29
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Bevacizumab, Temozolomide and Hypofractionated Radiotherapy for Patients With Newly Diagnosed Malignant Glioma
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-10-28
Start Date Type:
ACTUAL
Primary Completion Date:
2017-03-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-03-23
Completion Date Type:
ACTUAL
First Submit Date:
2008-10-29
First Submit QC Date:
None
Study First Post Date:
2008-10-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-12-13
Results First Submit QC Date:
None
Results First Post Date:
2018-02-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-01-10
Last Update Post Date:
2018-02-06
Last Update Post Date Type:
ACTUAL